tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Solid Biosciences price target raised to $17 from $14 at Wedbush
PremiumThe FlySolid Biosciences price target raised to $17 from $14 at Wedbush
8d ago
Solid Biosciences: INSPIRE DUCHENNE Data and FDA Pathway Support Overweight/Buy Rating on SGT-003 Gene Therapy Upside
Premium
Ratings
Solid Biosciences: INSPIRE DUCHENNE Data and FDA Pathway Support Overweight/Buy Rating on SGT-003 Gene Therapy Upside
8d ago
Solid Biosciences Reports Encouraging Phase 1/2 Duchenne Data
Premium
Company Announcements
Solid Biosciences Reports Encouraging Phase 1/2 Duchenne Data
8d ago
Solid Biosciences Announces $240 Million Private Placement Financing
PremiumCompany AnnouncementsSolid Biosciences Announces $240 Million Private Placement Financing
13d ago
Solid Biosciences prices 14.97M shares at $5.61 in private placement
Premium
The Fly
Solid Biosciences prices 14.97M shares at $5.61 in private placement
14d ago
Solid Biosciences reaches FDA alignment on IMPACT DUCHENNE study design
Premium
The Fly
Solid Biosciences reaches FDA alignment on IMPACT DUCHENNE study design
1M ago
Solid Biosciences: Advancing DMD Gene Therapy Toward 2026 Value Inflection With Accelerated Approval Potential
PremiumRatingsSolid Biosciences: Advancing DMD Gene Therapy Toward 2026 Value Inflection With Accelerated Approval Potential
2M ago
FDA grants Solid Biosciences orphan drug designation for SGT-212
Premium
The Fly
FDA grants Solid Biosciences orphan drug designation for SGT-212
2M ago
Solid Biosciences doses first participant in Phase 1b FALCON trial on SGT-212
Premium
The Fly
Solid Biosciences doses first participant in Phase 1b FALCON trial on SGT-212
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100